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ABSTRACT
Merkel cell carcinoma (MCC) is a rare but aggressive 
neuroendocrine skin cancer. To diagnose nodal MCC 
with an unknown primary disease is challenging, 
and it has to be separated from other nodal metastatic 
neoplasms. We report a unique case of nodal MCC in 
head and neck lesions with an unknown primary. A 
70-year-old woman was admitted to our department 
with a right submandibular mass. Fine needle aspiration 
biopsy was performed and indicated malignancy. F-18-
f luorodeoxyglucose positron emission tomography 
(PET) demonstrated abnormal accumulation in the 
right submandibular lymph node, right palatine tonsil, 
and right thyroid gland. For diagnostics and treatment, 
bilateral selective neck lymph node dissection, right 
tonsillectomy, and right thyroidectomy were performed. 
Histopathological examination revealed that most parts 
of the submandibular lymph node were occupied by 
diffuse sheets of tumor cells. Contrary to our expecta-
tion, malignant cells were not detected in the right 
palatine tonsil and right thyroid. Immunohistochemistry 
demonstrated a marked positive reaction for AE1/
AE3, chromogranin A, synaptophysin, cytokeratin 20 
(CK20) and CD56 and a negative reaction for vimentin, 
leucocyte common antigen (LCA), thyroid transcription 
factor-1 (TTF1) and cytokeratin 7 (CK7) in the tumor 
cells. Immunostaining of Merkel cell polyomavirus-
large T antigen (MCPyV-LT) showed a positive reaction 
and MCPyV-positive MCCs were assessed by PCR 
analysis, demonstrating that viral copy number was 12.8 
copies per cell. These histological findings confirmed 
the diagnosis of Merkel cell carcinoma of the lymph 
node. In cases of tumors in the lymph node with a neu-
roendocrine appearance in head and neck lesions, it is 
necessary to eliminate the possibility of metastasis from 
MCC.
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Merkel cell carcinoma (MCC) is a rare but aggressive 
neuroendocrine skin cancer.1–3 Although Merkel cells 
are believed to be the source of MCC, the cells of origin 
in MCC remain a controversial issue. Uncommonly, 
cases of high-grade neuroendocrine tumors have been 
encountered in lymph nodes with unknown extra-nodal 
primary disease, and these tumors are usually described 
as ‘nodal MCC with unknown primary’.4–7 However, 
it has been unclear whether nodal MCC is a primary 
tumor of the lymph node itself or if it represents a me-
tastasis from an occult or regressed extra-nodal lesion. 
Here, we present a unique case of nodal MCC in a head 
and neck lesion with an unknown primary.
PATIENT REPORT
A 70-year-old woman was admitted to our department 
with a right, 3 cm round and immobile submandibular 
mass. Computed tomography revealed that 3 cm and 
2cm mass were observed in the right submandibular. 
Endoscopic examination did not reveal any primary le-
sion in head and neck regions. Fine-needle aspiration bi-
opsy (FNA) of submandibular mass was performed and 
revealed that the gathered individual cells had a nucleus 
with irregular contour and fine chromatin, with a high 
nucleo-cytoplasmic and thin perinuclear edges. These 
findings were not in accordance with typical squamous 
cell carcinoma (SCC) and malignant lymphoma and me-
tastasis of neuroendocrine tumor was firstly considered 
(Fig. 1). For detection of primary lesion and staging, 
F-18-fluorodeoxyglucose positron emission tomography 
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(PET) was conducted. PET demonstrated abnormal 
accumulation in the right submandibular lymph node, 
right palatine tonsil, and right thyroid gland (Fig. 2). 
The serological data showed serum ProGRP 155.8 pg/
mL (baseline: 0–81), NSE13.7 ng/mL (baseline: 0–16.3). 
For diagnostics and treatment, bilateral selective neck 
lymph node dissection (I–V), right tonsillectomy and 
right thyroidectomy were performed. Histopathological 
examination revealed that most parts of the lymph 
node were occupied by diffuse sheets of tumor cells. 
Moreover, the tumor cells were uniformly small 
rounded cells with scanty cytoplasm and had a round to 
oval nucleus with dispersed chromatin, and inconspicu-
ous nucleoli in right IB, IIA and IIB lymph nodes (Fig. 
3). Contrary to our expectation, malignant cells were 
not detected in the right palatine tonsil and right thyroid 
gland. Immunohistochemistry demonstrated a marked 
positive reaction for AE1/AE3, chromogranin A, synap-
tophysin, cytokeratin 20 (CK20) and CD56 and a nega-
tive reaction for vimentin, leucocyte common antigen 
(LCA), thyroid transcription factor-1 (TTF1) and CK7 
in the tumor cells (Fig. 4). The Ki-67 staining index 
ranged from 50 to 60%. Immunostaining of Merkel cell 
polyomavirus-large T antigen (MCPyV-LT) showed 
a positive reaction and MCPyV-positive MCCs were 
assessed by PCR analysis, demonstrating that the viral 
copy number was 12.8 copies per cell (Fig. 5). These 
histological findings confirmed the diagnosis of nodal 
MCC in head and neck lesions with primary unknown 
(stage IIIA). The patient underwent treatment with 
carboplatin (CBDCA) and irinotecan (CPT-11) chemo-
therapy. Right superior deep lateral cervical lymph node 
swelling was observed eight months after the initial 
treatment. Resection of the lymph node was performed 
and histological findings confirmed the same results as 
the initial surgery. She has since undergone treatment 
with CBDCA and etoposide (VP-16) chemotherapy 
and radiation therapy (60Gy/25 fractions). Two years 
later, the patient was in good clinical conditions without 
recurrence.
DISCUSSION
Nodal MCC with unknown primary is defined as neuro-
endocrine carcinoma in lymph nodes with microscopic, 
immunohistochemical, and genetic features similar to 
those of cutaneous MCC.8–10 In our case, we initially 
could not diagnose MCC based on morphological 
features. However, FNA was very useful as a diagnostic 
tool in differential diagnosis from SCC and malignant 
lymphoma. It is generally difficult to diagnose MCC 
Fig. 1. Fine-needle aspiration biopsy (FNA) revealed that the individual cells had a nucleus with irregular 
contours and showed fine chromatin.
260
R. Ikeda et al.
© 2019 Tottori University Medical Press
solely by morphologic characteristics. Therefore, 
several metastatic tumors should be considered in the 
differential diagnosis such as metastatic neuroendocrine 
carcinoma including small cell carcinoma from the 
lung or genitourinary tract, malignant melanoma, 
B-cell lymphoblastic lymphoma, and mature B-cell 
lymphoma. Immunohistochemistry is also a key tool 
to identify the diagnosis of MCC. MCC is positive 
for neuroendocrine markers such as synaptophysin, 
chromogranin A and CD56. However, the specificity of 
these markers is low. In our case, the cells were positive 
for synaptophysin and chromogranin A, but negative 
for CD56. CK20 and TTF-1 are useful in distinguishing 
MCC from metastatic small cell carcinoma. CK20 is a 
low molecular weight cytokeratin that is only expressed 
in normal gastrointestinal epithelia, urothelia, and 
Merkel cells. MCC almost always stains with CK20 
in contrast to metastatic SCC.11 TTF-1 is described as 
a nuclear transcription factor expressed in epithelial 
cells of the thyroid and lung. It is expressed in a high 
proportion of SCC and is not expressed by MCC.12 
Most cases of MCC are CK7-negative, but a significant 
Fig. 2. F-18-fluorodeoxyglucose positron emission tomography (PET) confirmed the presence of abnormal accumulation in the 
right submandibular lymph node, right palatine tonsil, and right thyroid gland.
Fig. 3. Histology showed most parts of the lymph node were occupied by tumor, nodules and diffuse sheets of eosinophilic cells with 
imperceptible cytoplasm, a round nuclei and dispersed chromatin (hematoxylin and eosin stain).
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Fig. 4. Immunohistochemistry of AE1/AE3 (a), vimentin (b), chromogranin A (c), synaptophysin (d), Ki67 (e) 
and CK20 (arrows: positive cells) (f).
Fig. 5. Immunohistochemistry of MCPyV-LT (Merkel cell polyomavirus-large T antigen).
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minority exhibit partial CK7 positivity. CK-7 was nega-
tive in our case. MCPyV is a non-enveloped double-
stranded DNA virus associated with the pathogenesis 
of MCC.13, 14 It is suggested that clonal integration of 
a polyomavirus might be involved in pathogenesis of 
MCC.13 MCPyV-LT is highly specific for MCC and 
the overexpression of MCPyV was also detected in our 
case. Detection of MCPyV-LT is clinically important 
and might help physicians in the diagnosis of MCC. 
These findings may allow us to speculate that MCPyV 
might contribute to the pathogenesis of MCC and 
MCPyV-LT might be used as an additional indicator of 
MCC. Patients with nodal MCC have a better prognosis 
than those with metastatic nodal MCC and a concurrent 
primary tumor.15–19 Surgical excision of the primary le-
sion and additional chemotherapy remain central in the 
treatment of nodal MCC with primary unknown. In re-
current cases, chemotherapy and radiotherapy have been 
standard treatment modalities.18, 19 A different regimen 
from initial treatment was selected from consideration 
of drug sensitivity in our case. However, recent reports 
demonstrated that PD-1 and PD-L1 inhibitors have been 
shown to be superior to other systemic treatments for 
MCC in advanced stages.1, 2 The use of these therapies 
are thus first-line treatment in advanced stages, espe-
cially because the side effects of these substances are 
generally easily controlled.2
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